SCLX FY 2020 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$72M

FY 2020 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$24M+12.0% YoY

Gross Profit

$21M90.9% margin

Operating Income

-$35M-149.7% margin

Net Income

-$48M-201.7% margin

EPS (Diluted)

$-0.01

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$82M

Total Liabilities

$223M

Stockholders' Equity

-$142M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$21M	+12.0%
Gross Profit	$21M	$15M	+40.6%
Operating Income	-$35M	-$139M	+74.6%
Net Income	-$48M	-$179M	+73.4%